Compile Data Set for Download or QSAR
Found 100 with Last Name = 'brink' and Initial = 'm'
TargetCytochrome P450 3A4(Homo sapiens (Human))
Amgen, Inc.

Curated by ChEMBL
LigandPNGBDBM50361983(CHEMBL1939697)copy SMILEScopy InChI
Affinity DataKi:  730nMAssay Description:Inhibition of CYP3A4 in human liver microsomes using midazolam as substrate assessed as unbound inhibitor concentration required for half maximal enz...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N254QPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Amgen, Inc.

Curated by ChEMBL
LigandPNGBDBM50361983(CHEMBL1939697)copy SMILEScopy InChI
Affinity DataKi:  740nMAssay Description:Inhibition of CYP3A4 in human liver microsomes using testosterone as substrate assessed as unbound inhibitor concentration required for half maximal ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N254QPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Amgen, Inc.

Curated by ChEMBL
LigandPNGBDBM50361983(CHEMBL1939697)copy SMILEScopy InChI
Affinity DataKi:  1.90E+3nMAssay Description:Inhibition of CYP3A4 in human liver microsomes using testosterone as substrate assessed as residual enzyme activity after 2 to 10 mins by LC-MS/MS an...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N254QPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Amgen, Inc.

Curated by ChEMBL
LigandPNGBDBM50361983(CHEMBL1939697)copy SMILEScopy InChI
Affinity DataKi:  1.90E+3nMAssay Description:Inhibition of CYP3A4 in human liver microsomes using midazolam as substrate assessed as residual enzyme activity after 2 to 10 mins by LC-MS/MS analy...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N254QPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Amgen, Inc.

Curated by ChEMBL
LigandPNGBDBM50371232(CARNOSIC ACID)copy SMILEScopy InChI
Affinity DataKi:  4.30E+3nMAssay Description:Inhibition of CYP3A4 activity in human hepatocytes after 30 mins by liquid chromatography/tandem mass spectroscopyMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24Q7WQXPubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Amgen Inc.

Curated by ChEMBL
LigandPNGBDBM50371232(CARNOSIC ACID)copy SMILEScopy InChI
Affinity DataKi:  9.20E+3nMAssay Description:Inhibition of CYP2C9 activity in human hepatocytes after 30 mins by liquid chromatography/tandem mass spectroscopyMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24Q7WQXPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008271(CHEMBL3235132)copy SMILEScopy InChI
Affinity DataIC50: 8nMAssay Description:Inhibition of human TAF1a using hippuryl-L-arginine/hippuryl-L-lysine as substrate by liquid chromatographic analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 3A4(Homo sapiens (Human))
Amgen, Inc.

Curated by ChEMBL
LigandPNGBDBM50361983(CHEMBL1939697)copy SMILEScopy InChI
Affinity DataIC50: 27nMAssay Description:Time dependent inhibition of CYP3A4 in human liver microsomes using midazolam as substrate preincubated for 30 mins followed by 10-fold dilution and ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N254QPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008279(CHEMBL3235140)copy SMILEScopy InChI
Affinity DataIC50: 41nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008272(CHEMBL3235133)copy SMILEScopy InChI
Affinity DataIC50: 41nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008278(CHEMBL3235139)copy SMILEScopy InChI
Affinity DataIC50: 66nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Amgen, Inc.

Curated by ChEMBL
LigandPNGBDBM50361983(CHEMBL1939697)copy SMILEScopy InChI
Affinity DataIC50: 68nMAssay Description:Time dependent inhibition of CYP3A4 in human liver microsomes using testosterone as substrate preincubated for 30 mins followed by 10-fold dilution a...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N254QPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008271(CHEMBL3235132)copy SMILEScopy InChI
Affinity DataIC50: 76nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008273(CHEMBL3235134)copy SMILEScopy InChI
Affinity DataIC50: 80nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008269(CHEMBL3235130)copy SMILEScopy InChI
Affinity DataIC50: 87nMAssay Description:Inhibition of human TAF1a using hippuryl-L-arginine/hippuryl-L-lysine as substrate by liquid chromatographic analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Amgen, Inc.

Curated by ChEMBL
LigandPNGBDBM50004704((+)-cis-Diltiazem | (2S,3S)-5-(2-(dimethylamino)et...)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Time dependent inhibition of CYP3A4 in human liver microsomes using midazolam as substrate preincubated for 90 mins followed by 10-fold dilution and ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N254QPubMedDrugBank
TargetCytochrome P450 3A4(Homo sapiens (Human))
Amgen, Inc.

Curated by ChEMBL
LigandPNGBDBM50004704((+)-cis-Diltiazem | (2S,3S)-5-(2-(dimethylamino)et...)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Time dependent inhibition of CYP3A4 in human liver microsomes using testosterone as substrate preincubated for 90 mins followed by 10-fold dilution a...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N254QPubMedDrugBank
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008272(CHEMBL3235133)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008274(CHEMBL3235135)copy SMILEScopy InChI
Affinity DataIC50: 106nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008273(CHEMBL3235134)copy SMILEScopy InChI
Affinity DataIC50: 117nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008275(CHEMBL3235136)copy SMILEScopy InChI
Affinity DataIC50: 124nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008269(CHEMBL3235130)copy SMILEScopy InChI
Affinity DataIC50: 400nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50226610((2S)-5-AMINO-2-[(1-PROPYL-1H-IMIDAZOL-4-YL)METHYL]...)copy SMILEScopy InChI
Affinity DataIC50: 450nMAssay Description:Inhibition of human TAF1a using hippuryl-L-arginine/hippuryl-L-lysine as substrate by liquid chromatographic analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008276(CHEMBL3235137)copy SMILEScopy InChI
Affinity DataIC50: 585nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008270(CHEMBL3235131)copy SMILEScopy InChI
Affinity DataIC50: 620nMAssay Description:Inhibition of human TAF1a using hippuryl-L-arginine/hippuryl-L-lysine as substrate by liquid chromatographic analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Amgen, Inc.

Curated by ChEMBL
LigandPNGBDBM50361983(CHEMBL1939697)copy SMILEScopy InChI
Affinity DataIC50: 650nMAssay Description:Time dependent inhibition of CYP3A4 in human liver microsomes using midazolam as substrate preincubated for 30 mins followed by 10-fold dilution and ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N254QPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008271(CHEMBL3235132)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008278(CHEMBL3235139)copy SMILEScopy InChI
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50135933(3-(6-Amino-pyridin-3-yl)-2-(1H-imidazol-4-yl)-prop...)copy SMILEScopy InChI
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibition of human TAF1a using hippuryl-L-arginine/hippuryl-L-lysine as substrate by liquid chromatographic analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Amgen, Inc.

Curated by ChEMBL
LigandPNGBDBM50361983(CHEMBL1939697)copy SMILEScopy InChI
Affinity DataIC50: 2.10E+3nMAssay Description:Time dependent inhibition of CYP3A4 in human liver microsomes using testosterone as substrate preincubated for 30 mins followed by 10-fold dilution a...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N254QPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008277(CHEMBL3235138)copy SMILEScopy InChI
Affinity DataIC50: 2.27E+3nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008274(CHEMBL3235135)copy SMILEScopy InChI
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Amgen, Inc.

Curated by ChEMBL
LigandPNGBDBM50211114((-)-(R)-N-(1-(3-(4-ethoxyphenyl)-4-oxo-3,4-dihydro...)copy SMILEScopy InChI
Affinity DataIC50: 2.70E+3nMAssay Description:Time dependent inhibition of CYP3A4 in human liver microsomes using midazolam as substrate preincubated for 90 mins followed by 10-fold dilution and ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N254QPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Amgen, Inc.

Curated by ChEMBL
LigandPNGBDBM50211114((-)-(R)-N-(1-(3-(4-ethoxyphenyl)-4-oxo-3,4-dihydro...)copy SMILEScopy InChI
Affinity DataIC50: 2.90E+3nMAssay Description:Time dependent inhibition of CYP3A4 in human liver microsomes using midazolam as substrate preincubated for 90 mins followed by substrate addition by...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N254QPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008279(CHEMBL3235140)copy SMILEScopy InChI
Affinity DataIC50: 3.20E+3nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50226610((2S)-5-AMINO-2-[(1-PROPYL-1H-IMIDAZOL-4-YL)METHYL]...)copy SMILEScopy InChI
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Amgen, Inc.

Curated by ChEMBL
LigandPNGBDBM50211114((-)-(R)-N-(1-(3-(4-ethoxyphenyl)-4-oxo-3,4-dihydro...)copy SMILEScopy InChI
Affinity DataIC50: 5.20E+3nMAssay Description:Time dependent inhibition of CYP3A4 in human liver microsomes using midazolam as substrate preincubated for 30 mins followed by 10-fold dilution and ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N254QPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Amgen, Inc.

Curated by ChEMBL
LigandPNGBDBM50211114((-)-(R)-N-(1-(3-(4-ethoxyphenyl)-4-oxo-3,4-dihydro...)copy SMILEScopy InChI
Affinity DataIC50: 5.70E+3nMAssay Description:Time dependent inhibition of CYP3A4 in human liver microsomes using midazolam as substrate preincubated for 30 mins followed by substrate addition by...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N254QPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Amgen, Inc.

Curated by ChEMBL
LigandPNGBDBM50211114((-)-(R)-N-(1-(3-(4-ethoxyphenyl)-4-oxo-3,4-dihydro...)copy SMILEScopy InChI
Affinity DataIC50: 7.00E+3nMAssay Description:Time dependent inhibition of CYP3A4 in human liver microsomes using midazolam as substrate preincubated for 30 mins followed by 10-fold dilution and ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N254QPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008276(CHEMBL3235137)copy SMILEScopy InChI
Affinity DataIC50: 7.10E+3nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Amgen, Inc.

Curated by ChEMBL
LigandPNGBDBM50211114((-)-(R)-N-(1-(3-(4-ethoxyphenyl)-4-oxo-3,4-dihydro...)copy SMILEScopy InChI
Affinity DataIC50: 8.00E+3nMAssay Description:Time dependent inhibition of CYP3A4 in human liver microsomes using midazolam as substrate preincubated for 90 mins followed by 10-fold dilution and ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N254QPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008270(CHEMBL3235131)copy SMILEScopy InChI
Affinity DataIC50: 8.00E+3nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Amgen, Inc.

Curated by ChEMBL
LigandPNGBDBM50004704((+)-cis-Diltiazem | (2S,3S)-5-(2-(dimethylamino)et...)copy SMILEScopy InChI
Affinity DataIC50: 8.10E+3nMAssay Description:Time dependent inhibition of CYP3A4 in human liver microsomes using testosterone as substrate preincubated for 30 mins followed by 10-fold dilution a...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N254QPubMedDrugBank
TargetCytochrome P450 3A4(Homo sapiens (Human))
Amgen, Inc.

Curated by ChEMBL
LigandPNGBDBM50211114((-)-(R)-N-(1-(3-(4-ethoxyphenyl)-4-oxo-3,4-dihydro...)copy SMILEScopy InChI
Affinity DataIC50: 8.30E+3nMAssay Description:Time dependent inhibition of CYP3A4 in human liver microsomes using midazolam as substrate preincubated for 30 mins followed by substrate addition by...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N254QPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Amgen, Inc.

Curated by ChEMBL
LigandPNGBDBM50211114((-)-(R)-N-(1-(3-(4-ethoxyphenyl)-4-oxo-3,4-dihydro...)copy SMILEScopy InChI
Affinity DataIC50: 9.20E+3nMAssay Description:Time dependent inhibition of CYP3A4 in human liver microsomes using midazolam as substrate preincubated for 90 mins followed by substrate addition by...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N254QPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Amgen, Inc.

Curated by ChEMBL
LigandPNGBDBM50004704((+)-cis-Diltiazem | (2S,3S)-5-(2-(dimethylamino)et...)copy SMILEScopy InChI
Affinity DataIC50: 9.60E+3nMAssay Description:Time dependent inhibition of CYP3A4 in human liver microsomes using testosterone as substrate preincubated for 90 mins followed by substrate addition...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N254QPubMedDrugBank
TargetCytochrome P450 3A4(Homo sapiens (Human))
Amgen, Inc.

Curated by ChEMBL
LigandPNGBDBM50004704((+)-cis-Diltiazem | (2S,3S)-5-(2-(dimethylamino)et...)copy SMILEScopy InChI
Affinity DataIC50: 1.20E+4nMAssay Description:Time dependent inhibition of CYP3A4 in human liver microsomes using midazolam as substrate preincubated for 30 mins followed by 10-fold dilution and ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N254QPubMedDrugBank
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008275(CHEMBL3235136)copy SMILEScopy InChI
Affinity DataIC50: 1.60E+4nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Amgen, Inc.

Curated by ChEMBL
LigandPNGBDBM50004704((+)-cis-Diltiazem | (2S,3S)-5-(2-(dimethylamino)et...)copy SMILEScopy InChI
Affinity DataIC50: 1.90E+4nMAssay Description:Time dependent inhibition of CYP3A4 in human liver microsomes using midazolam as substrate preincubated for 90 mins followed by substrate addition by...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N254QPubMedDrugBank
TargetCytochrome P450 3A4(Homo sapiens (Human))
Amgen, Inc.

Curated by ChEMBL
LigandPNGBDBM50211114((-)-(R)-N-(1-(3-(4-ethoxyphenyl)-4-oxo-3,4-dihydro...)copy SMILEScopy InChI
Affinity DataIC50: 2.00E+4nMAssay Description:Time dependent inhibition of CYP3A4 in human liver microsomes using testosterone as substrate preincubated for 30 mins followed by substrate addition...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N254QPubMed
Displayed 1 to 50 (of 100 total ) | Next | Last >>
Jump to: